163 related articles for article (PubMed ID: 34041039)
21. Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling.
Frontiers Editorial Office
Front Oncol; 2021; 11():738970. PubMed ID: 34532292
[TBL] [Abstract][Full Text] [Related]
22. Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice.
Li L; Song L; Liu X; Yang X; Li X; He T; Wang N; Yang S; Yu C; Yin T; Wen Y; He Z; Wei X; Su W; Wu Q; Yao S; Gong C; Wei Y
ACS Nano; 2017 Jan; 11(1):95-111. PubMed ID: 28114767
[TBL] [Abstract][Full Text] [Related]
23. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
[TBL] [Abstract][Full Text] [Related]
24. Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.
Frontiers Editorial Office
Front Oncol; 2021; 11():721658. PubMed ID: 34277459
[TBL] [Abstract][Full Text] [Related]
25. Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma
Frontiers Editorial Office
Front Oncol; 2021; 11():721663. PubMed ID: 34249769
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.
Zhao G; Wang Q; Gu Q; Qiang W; Wei JJ; Dong P; Watari H; Li W; Yue J
Oncotarget; 2017 Nov; 8(55):94666-94680. PubMed ID: 29212257
[TBL] [Abstract][Full Text] [Related]
27. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
28. Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8.
Frontiers Editorial Office
Front Oncol; 2023; 13():1307324. PubMed ID: 37927471
[TBL] [Abstract][Full Text] [Related]
29. Emerging CRISPR/Cas9 applications for T-cell gene editing.
Preece R; Georgiadis C
Emerg Top Life Sci; 2019 May; 3(3):261-275. PubMed ID: 33523139
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9-Based Gene Editing in Soybean.
Bao A; Tran LP; Cao D
Methods Mol Biol; 2020; 2107():349-364. PubMed ID: 31893458
[TBL] [Abstract][Full Text] [Related]
31. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
32. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Wu HY; Cao CY
Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
[TBL] [Abstract][Full Text] [Related]
33. Efficiency Optimization of CRISPR/Cas9-Mediated Targeted Mutagenesis in Grape.
Ren F; Ren C; Zhang Z; Duan W; Lecourieux D; Li S; Liang Z
Front Plant Sci; 2019; 10():612. PubMed ID: 31156675
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool.
Yang F; Liu C; Chen D; Tu M; Xie H; Sun H; Ge X; Tang L; Li J; Zheng J; Song Z; Qu J; Gu F
Mol Ther Nucleic Acids; 2017 Jun; 7():378-386. PubMed ID: 28624213
[TBL] [Abstract][Full Text] [Related]
35. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
[TBL] [Abstract][Full Text] [Related]
36. Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1298859. PubMed ID: 38115901
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
38. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
39. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
40. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]